176 related articles for article (PubMed ID: 30387921)
1. LncRNA-Jak3:Jak3 coexpressed pattern regulates monosodium urate crystal-induced osteoclast differentiation through Nfatc1/Ctsk expression.
Lee CP; Huang YN; Nithiyanantham S; Huang CM; Ko YC
Environ Toxicol; 2019 Feb; 34(2):179-187. PubMed ID: 30387921
[TBL] [Abstract][Full Text] [Related]
2. Monosodium Urate in the Presence of RANKL Promotes Osteoclast Formation through Activation of c-Jun N-Terminal Kinase.
Choe JY; Park KY; Kim SK
Mediators Inflamm; 2015; 2015():597512. PubMed ID: 26347587
[TBL] [Abstract][Full Text] [Related]
3. AP-1 and Mitf interact with NFATc1 to stimulate cathepsin K promoter activity in osteoclast precursors.
Pang M; Rodríguez-Gonzalez M; Hernandez M; Recinos CC; Seldeen KL; Troen BR
J Cell Biochem; 2019 Aug; 120(8):12382-12392. PubMed ID: 30816596
[TBL] [Abstract][Full Text] [Related]
4. LncRNA XIST facilitates S1P-mediated osteoclast differentiation via interacting with FUS.
Zhang DW; Wang HG; Zhang KB; Guo YQ; Yang LJ; Lv H
J Bone Miner Metab; 2022 Mar; 40(2):240-250. PubMed ID: 35066669
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-124 regulates osteoclast differentiation.
Lee Y; Kim HJ; Park CK; Kim YG; Lee HJ; Kim JY; Kim HH
Bone; 2013 Oct; 56(2):383-9. PubMed ID: 23867221
[TBL] [Abstract][Full Text] [Related]
6. Diarylheptanoid from Curcuma comosa Roxb. suppresses RANKL-induced osteoclast differentiation by decreasing NFATc1 and c-Fos expression via MAPK pathway.
Chawalitpong S; Sornkaew N; Suksamrarn A; Palaga T
Eur J Pharmacol; 2016 Oct; 788():351-359. PubMed ID: 27523282
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory Effect of Purpurogallin on Osteoclast Differentiation in Vitro through the Downregulation of c-Fos and NFATc1.
Kim K; Kim TH; Ihn HJ; Kim JE; Choi JY; Shin HI; Park EK
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463002
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rb2 inhibits osteoclast differentiation through nuclear factor-kappaB and signal transducer and activator of transcription protein 3 signaling pathway.
Cong F; Liu J; Wang C; Yuan Z; Bi L; Liang J; Su K; Qiu Y; Song T; Fan J; Chao G
Biomed Pharmacother; 2017 Aug; 92():927-934. PubMed ID: 28605877
[TBL] [Abstract][Full Text] [Related]
9. Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT.
Hong G; Zhou L; Shi X; He W; Wang H; Wei Q; Chen P; Qi L; Tickner J; Lin L; Xu J
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106828
[TBL] [Abstract][Full Text] [Related]
10. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand.
Balkan W; Martinez AF; Fernandez I; Rodriguez MA; Pang M; Troen BR
Gene; 2009 Oct; 446(2):90-8. PubMed ID: 19563866
[TBL] [Abstract][Full Text] [Related]
11. Caffeine enhances osteoclast differentiation and maturation through p38 MAP kinase/Mitf and DC-STAMP/CtsK and TRAP pathway.
Choi J; Choi SY; Lee SY; Lee JY; Kim HS; Lee SY; Lee NK
Cell Signal; 2013 May; 25(5):1222-7. PubMed ID: 23434822
[TBL] [Abstract][Full Text] [Related]
12. STAT3 controls osteoclast differentiation and bone homeostasis by regulating NFATc1 transcription.
Yang Y; Chung MR; Zhou S; Gong X; Xu H; Hong Y; Jin A; Huang X; Zou W; Dai Q; Jiang L
J Biol Chem; 2019 Oct; 294(42):15395-15407. PubMed ID: 31462535
[TBL] [Abstract][Full Text] [Related]
13. Aconine inhibits RANKL-induced osteoclast differentiation in RAW264.7 cells by suppressing NF-κB and NFATc1 activation and DC-STAMP expression.
Zeng XZ; He LG; Wang S; Wang K; Zhang YY; Tao L; Li XJ; Liu SW
Acta Pharmacol Sin; 2016 Feb; 37(2):255-63. PubMed ID: 26592521
[TBL] [Abstract][Full Text] [Related]
14. ATF3 modulates calcium signaling in osteoclast differentiation and activity by associating with c-Fos and NFATc1 proteins.
Jeong BC; Kim JH; Kim K; Kim I; Seong S; Kim N
Bone; 2017 Feb; 95():33-40. PubMed ID: 27829167
[TBL] [Abstract][Full Text] [Related]
15. The inhibitory effect and the molecular mechanism of glabridin on RANKL-induced osteoclastogenesis in RAW264.7 cells.
Kim HS; Suh KS; Sul D; Kim BJ; Lee SK; Jung WW
Int J Mol Med; 2012 Feb; 29(2):169-77. PubMed ID: 22038020
[TBL] [Abstract][Full Text] [Related]
16. C/ebpα controls osteoclast terminal differentiation, activation, function, and postnatal bone homeostasis through direct regulation of Nfatc1.
Chen W; Zhu G; Tang J; Zhou HD; Li YP
J Pathol; 2018 Mar; 244(3):271-282. PubMed ID: 29083488
[TBL] [Abstract][Full Text] [Related]
17. Fluid Shear Stress Suppresses Osteoclast Differentiation in RAW264.7 Cells through Extracellular Signal-Regulated Kinase 5 (ERK5) Signaling Pathway.
Ma C; Geng B; Zhang X; Li R; Yang X; Xia Y
Med Sci Monit; 2020 Jan; 26():e918370. PubMed ID: 31914120
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of cantharidin on osteoclast differentiation and bone resorption.
Kim MH; Shim KS; Kim SH
Arch Pharm Res; 2010 Mar; 33(3):457-62. PubMed ID: 20361312
[TBL] [Abstract][Full Text] [Related]
19. New Function of RUNX2 in Regulating Osteoclast Differentiation via the AKT/NFATc1/CTSK Axis.
Xin Y; Liu Y; Liu D; Li J; Zhang C; Wang Y; Zheng S
Calcif Tissue Int; 2020 May; 106(5):553-566. PubMed ID: 32008052
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of tert-butylhydroquinone on osteoclast differentiation via up-regulation of heme oxygenase-1 and down-regulation of HMGB1 release and NFATc1 expression.
Yamaguchi Y; Sakai E; Sakamoto H; Fumimoto R; Fukuma Y; Nishishita K; Okamoto K; Tsukuba T
J Appl Toxicol; 2014 Jan; 34(1):49-56. PubMed ID: 23112101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
